Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Drug Use Investigation Of Zyvox (Linezolid) (Regulatory Post Marketing Commitment Plan).

Trial Profile

Drug Use Investigation Of Zyvox (Linezolid) (Regulatory Post Marketing Commitment Plan).

Phase of Trial: Phase IV

Latest Information Update: 29 Jun 2012

At a glance

  • Drugs Linezolid (Primary)
  • Indications Methicillin-resistant Staphylococcus aureus infections
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 06 Jun 2011 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
    • 06 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Dec 2009 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top